Puma biotechnology sale press release
Puma biotechnology sale press release
Puma biotechnology sale press release
Puma biotechnology sale press release
Puma biotechnology sale press release
Puma biotechnology sale press release

Puma biotechnology sale press release

Puma biotechnology sale press release, Puma Biotechnology Reports Results of PB272 neratinib in P III sale

$43.00

SKU: 7571804

Colour
  • Marketing Application for Early Stage Breast Cancer Therapy
  • Puma Biotechnology Inc. PBYI Stock Price Quote News Stock
  • Puma Biotechnology Reports Inducement Award Under Nasdaq Listing
  • Puma Biotechnology Presents Interim Results of Phase II CONTROL
Out of stock
Personalised:
: ( x )
Personalisation:
Edit
Remove Personalisation
Frasers Plus

Buy now.

Pay later.

Earn rewards

Representative APR: 29.9% (variable)

Credit subject to status. Terms apply.

Missed payments may affect your credit score

FrasersPlus